Agile Therapeutics Reports Third Quarter 2020 Financial Results
November 12, 2020 16:05 ET
|
Agile Therapeutics, Inc.
Commercial Launch of Twirla® Expected by Year-End 2020 $71.9 Million in Cash, Cash Equivalents, and Marketable Securities as of September 30, 2020 Management to Host Conference Call today at 4:30 PM...
Agile Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Provide Corporate and Twirla® Commercial Updates on Thursday, November 12, 2020
November 04, 2020 07:30 ET
|
Agile Therapeutics, Inc.
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will...
Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 22, 2020 11:40 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be virtually...
Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference
September 09, 2020 08:00 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that Al Altomari, Chairman and Chief...
Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020
September 08, 2020 08:00 ET
|
Agile Therapeutics, Inc.
Company to Present Twirla® Commercial Plan Webcast Scheduled from 11:00 am – 1:00 pm EDT PRINCETON, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's...
Agile Therapeutics Launches I’m So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control
September 02, 2020 09:00 ET
|
Agile Therapeutics, Inc.
Visit BirthControlDoneMyWay.com to learn more about some of the many available contraceptive options I’m So Done is a national unbranded campaign intended to enhance the birth control conversation...
Agile Therapeutics Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Chief Medical Officer
August 17, 2020 08:00 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced the appointment of Paul Korner, MD, MBA, to...
Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
August 11, 2020 16:02 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will...
Agile Therapeutics Reports Second Quarter 2020 Financial Results
August 11, 2020 16:01 ET
|
Agile Therapeutics, Inc.
Twirla® on Track for Commercial Launch in Fourth Quarter 2020 $87.2 Million in Cash and Cash Equivalents as of June 30, 2020 Management to Host Conference Call at 4:30 PM ET PRINCETON, N.J., Aug. ...
Agile Therapeutics to Host Second Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, August 11, 2020
July 21, 2020 07:30 ET
|
Agile Therapeutics, Inc.
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today...